Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
Catheter Precision, Inc., a Delaware corporation, filed this Current Report on Form 8-K on November 13, 2025. The filing serves to announce the Company's financial results for the three and nine months ended September 30, 2025. The detailed results are contained in a press release attached as Exhibit 99.1.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the body of this 8-K filing.
Material Changes
No specific material changes versus prior periods are detailed in this document. The filing indicates that the Company has issued results for the period ended September 30, 2025, but does not quantify the changes within this text.
Guidance, Outlook, and Risks
The filing does not provide specific guidance, outlook, management commentary, or risk factors. It explicitly states that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other SEC filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the three and nine months ended September 30, 2025.
- Verify the Company's liquidity position and debt levels in the attached press release, as these are not listed in the 8-K text.
- Confirm any year-over-year or quarter-over-quarter percentage changes in key metrics from the attached exhibit.
- Check for any forward-looking statements or updated guidance included in the press release.